- Home
- BBDO vs BNTX Comparison
BBDO vs BNTX Comparison
Compare BBDO & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBDO | BNTX |
|---|---|---|
| Founded | 1943 | 2008 |
| Country | Brazil | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | BBDO | BNTX |
|---|---|---|
| Price | $2.96 | $92.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $2.55 | ★ $137.40 |
| AVG Volume (30 Days) | 53.0K | ★ 1.3M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 4.98% | N/A |
| EPS Growth | ★ 47.11 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $16,507,289,161.00 | $3,698,814,972.00 |
| Revenue This Year | $78.26 | $2.36 |
| Revenue Next Year | $7.53 | N/A |
| P/E Ratio | $8.46 | ★ N/A |
| Revenue Growth | ★ 16.68 | 3.70 |
| 52 Week Low | $1.71 | $81.20 |
| 52 Week High | $3.31 | $129.27 |
Technical Indicators
Market Signals| Indicator | BBDO | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.93 | 33.13 |
| Support Level | $2.96 | $94.52 |
| Resistance Level | $3.08 | $97.35 |
| Average True Range (ATR) | 0.09 | 2.45 |
| MACD | -0.02 | -0.37 |
| Stochastic Oscillator | 33.75 | 6.01 |
Price Performance
Historical ComparisonAbout BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.